Presentation TCT 2022 Drug Elution: Challenges and Opportunities Presenter: Sahil Parikh September 18, 2022
Presentation TCT 2022 Coronary DCB in HBR Patients: An Alternative to DES? Presenter: Tuomas Rissanen September 18, 2022
Presentation TCT 2022 Role of Drug-Eluting Technologies as Definitive Therapy Presenter: Beau Hawkins September 18, 2022
Presentation TCT 2022 Reflow Medical’s Temporary Spur DES System Presenter: Jihad Mustapha September 17, 2022
Presentation TCT 2022 APTITUDE PLLA BRS (R3 Vascular) Presenter: Mahmood K. Razavi September 17, 2022
Presentation TCT 2022 Hybrid Nano-Coating DES for BTK Disease Presenter: Terumitsu Hasebe September 17, 2022
Presentation TCT 2022 World’s largest RCT for DM - ABILITY DIABETES GLOBAL: Implication and Importance Presenter: Marie-Claude Morice September 17, 2022
Presentation TCT 2022 Diabetes and DES+DCB platform: the perfect match Presenter: Luca Testa September 17, 2022
Presentation TCT 2022 The role of imaging in DM patients: case presentations from ABILITY RCT Presenter: Antonio Mangieri September 17, 2022
Presentation TCT 2022 The Innovative DES+DCB platform Presenter: Fazila-Tun-Nesa Malik September 17, 2022
Presentation TCT 2022 Hybrid Interventional Approach (DCB + DES): Clinical Indications, Available Data and Future Perspectives Presenter: Bruno Scheller September 17, 2022
Presentation TCT 2022 Stent-Free PCI (DCB Only Approach): Insights and Considerations from the SELUTION de NOVO Randomized Control Study Presenter: Christian M. Spaulding September 17, 2022
Presentation TCT 2022 Sirolimus DCBs: Technological Trends, Challenges and Advantages Presenter: Ron Waksman September 17, 2022
Presentation TCT 2022 Sirolimus Coated DCB in All-Comers EASTBOURNE (MagicTouch DCB) Presenter: Bernardo Cortese September 17, 2022
Presentation TCT 2022 DCB for SVD: Primary Outcomes of a Multi-Center RCT with AGENT DCB Presenter: Paul Underwood September 17, 2022
Presentation TCT 2022 5-Year RESTORE SVD China Trial: Restore DCB vs. DES Resolute Integrity in SVD Presenter: ShaoLiang Chen September 17, 2022
Presentation TCT 2022 3-Year Outcome of paclitaxel DCB vs. DES for Native Vessel Disease Treatment: Final Follow Up of the Randomized PICCOLETO II Trial Presenter: Bernardo Cortese September 17, 2022
Presentation TCT 2022 Time to Move Beyond ISR – My Vision of the Future for Coronary DCB Technologies Presenter: Antonio Colombo September 17, 2022